Maarja‐Liisa Nairismägi
National Cancer Centre Singapore(SG)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Immune Cell Function and Interaction, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers(2013)488 cited
- → Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma(2020)78 cited
- → Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma(2018)57 cited
- → Evaluation of the PIK3 pathway in peripheral T‐cell lymphoma and NK/T‐cell lymphoma(2020)34 cited
- → The Proto-Oncogene TWIST1 Is Regulated by MicroRNAs(2013)32 cited
- → Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphoma(2018)8 cited
- → Oncogenic activation of STAT3 pathway drives PD-L1 expression in natural killer/T cell lymphoma.(2017)6 cited
- → Abstract 5184: Distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers revealed by whole exome sequencing(2014)3 cited
- → Recurrent PD-L1 Structural Rearrangements in Natural Killer/T Cell Lymphoma Patients with Complete Response to PD-1 Blockade Therapy(2018)3 cited
- → ONCOGENIC ACTIVATION OF STAT3 PATHWAY DRIVES PD‐L1 EXPRESSION IN NATURAL KILLER/T CELL LYMPHOMA(2017)3 cited